Identification of ubiquitin Ser57 kinases regulating the oxidative stress response in yeast

  1. Nathaniel L Hepowit
  2. Kevin N Pereira
  3. Jessica M Tumolo
  4. Walter J Chazin
  5. Jason A MacGurn  Is a corresponding author
  1. Department of Cell and Developmental Biology, Vanderbilt University, United States
  2. Department of Biochemistry, Vanderbilt University, United States

Abstract

Ubiquitination regulates many different cellular processes, including protein quality control, membrane trafficking, and stress responses. The diversity of ubiquitin functions in the cell is partly due to its ability to form chains with distinct linkages that can alter the fate of substrate proteins in unique ways. The complexity of the ubiquitin code is further enhanced by post-translational modifications on ubiquitin itself, the biological functions of which are not well understood. Here, we present genetic and biochemical evidence that serine 57 (Ser57) phosphorylation of ubiquitin functions in stress responses in Saccharomyces cerevisiae, including the oxidative stress response. We also identify and characterize the first known Ser57 ubiquitin kinases in yeast and human cells, and we report that two Ser57 ubiquitin kinases regulate the oxidative stress response in yeast. These studies implicate ubiquitin phosphorylation at the Ser57 position as an important modifier of ubiquitin function, particularly in response to proteotoxic stress.

Introduction

Ubiquitin is a post-translational modifier that regulates diverse cellular processes in eukaryotic cells. The broad utility of ubiquitin as a regulatory modification is due to the high degree of complexity associated with ubiquitin polymers, which are added to substrate proteins by the activity of ubiquitin conjugation machinery (E1-E2-E3 cascades) and removed from substrates by deubiquitylases (DUBs). Ubiquitin can be conjugated recursively at any of seven internal lysines or the N-terminus to generate polymers with distinct topological features (Herhaus and Dikic, 2015; Yau and Rape, 2016; Swatek and Komander, 2016). Complexity is further enhanced by the formation of mixed and branched polymers (Ohtake et al., 2018; Meyer and Rape, 2014; Swatek et al., 2019) and by post-translational modifications that can occur on ubiquitin itself (Herhaus and Dikic, 2015). For example, PINK1-mediated phosphorylation of ubiquitin at the Ser65 position plays an important role in mitophagy by regulating parkin-mediated ubiquitination of mitochondrial membrane proteins (Wauer et al., 2015; Ordureau et al., 2015; Koyano et al., 2014; Kazlauskaite et al., 2014; Kane et al., 2014; Ordureau et al., 2014). Phosphorylation of ubiquitin at the Ser57 has also been reported (Peng et al., 2003; Swaney et al., 2015; Lee et al., 2017), but the kinases that produce this modification and its regulatory significance remain unknown.

Many proteotoxic stresses activate ubiquitin networks to promote protein quality control and protect the cell from damage associated with systemic protein misfolding. Oxidative stress is highly damaging to the cell, triggering deployment and re-distribution of existing ubiquitin pools and induction of ubiquitin biosynthesis to promote survival by activating a repertoire of ubiquitin-mediated responses (Cheng et al., 1994). During oxidative stress, many proteins become damaged and misfolded, resulting in a global increase in K48-linked ubiquitin conjugation that targets substrates for clearance by proteasome-mediated degradation (Finley, 2009; Shang and Taylor, 2011). Oxidative stress also triggers translation arrest (Grant, 2011), resulting in K63-linked polyubiquitylation on ribosomes to stabilize the 80S complex and the formation of polysomes (Silva et al., 2015). Furthermore, oxidative damage of DNA activates signaling and repair processes that are tightly regulated by K63 ubiquitylation and deubiquitylation activities (Demple and Harrison, 1994; Bergink and Jentsch, 2009; Ng et al., 2016; Croteau and Bohr, 1997; Thorslund et al., 2015). Thus, ubiquitin networks regulate many cellular processes critical for survival during conditions of oxidative stress.

Although ubiquitin networks play a critical role in the eukaryotic cellular response to proteotoxic stress, precisely how these networks are tuned to enhance protein quality control and other protective functions remain unclear. Given that Ser65 phosphorylation of ubiquitin regulates the clearance of damaged mitochondria (Wauer et al., 2015; Ordureau et al., 2015; Koyano et al., 2014; Kazlauskaite et al., 2014; Kane et al., 2014; Ordureau et al., 2014), we hypothesized that phosphorylation at other positions may regulate ubiquitin function, particularly in conditions that promote protein damage and misfolding. Since it is the most abundant phosphorylated form (Swaney et al., 2015), we examined the biological functions of Ser57 phosphorylated ubiquitin in yeast, aiming to identify and characterize the molecular events and signaling processes that regulate its production.

Results

To probe potential biological functions of Ser57 ubiquitin phosphorylation in yeast, we generated yeast strains expressing exclusively wildtype, Ser57Ala (phosphorylation resistant, or S57A) or Ser57Asp (phosphomimetic, or S57D) ubiquitin. It is important to emphasize that such complete ubiquitin replacement may exaggerate effects associated with physiological ubiquitin phosphorylation, which occurs at very low stoichiometry (Swaney et al., 2015; Lee et al., 2017) and probably in a highly localized manner (as exemplified by PINK1-mediated Ser65 phosphorylation of ubiquitin on damaged segments of mitochondrial membrane [Pickrell and Youle, 2015]). With these limitations in mind, we examined the growth of these yeast strains in the context of various stressors, including heat stress, DNA damage and replication stress (hydroxyurea and arsenate), and protein misfolding stress (canavanine and thialysine, which are toxic analogs of arginine and lysine, respectively). We found that expression of S57A or S57D ubiquitin did not affect growth at ambient temperature (26°C) (consistent with previous reports [Peng et al., 2003; Lee et al., 2017; Sloper-Mould et al., 2001]) or sensitivity to arsenate (Figure 1A). However, expression of S57D ubiquitin conferred sensitivity to hydroxyurea and resistance to canavanine (which was reported previously [Lee et al., 2017]) and thialysine (Figure 1A). We also noticed that expression of S57D ubiquitin enhanced both long-term and acute tolerance of thermal stress (Figure 1B–D) while yeast expressing S57A ubiquitin exhibited thermal sensitivity (Figure 1E and Figure 1—figure supplement 1). These findings indicate that Ser57 phosphorylation of ubiquitin promotes cellular tolerance of various proteotoxic stressors.

Figure 1 with 1 supplement see all
Genetic evidence of a role for Ser57 phosphorylation in the cellular response to stress.

Ubiquitin variants were shuffled into the SUB280 yeast background (as described in the Materials and Methods) to generate strains that express exclusively wildtype, S57A, or S57D ubiquitin. (A) Yeast strains expressing the indicated ubiquitin variants (wildtype, S57A or S57D) were plated in serial dilutions onto the indicated synthetic dextrose medium (SDM) agar plates. (B) Serial dilutions of yeast cells were plated onto YPD agar plates and incubated at 26°C, 37°C, or 39°C for 18 hr and shifted back to 26°C for recovery. (C) Fluorescence microscopy and (D) quantification of cells stained with propidium iodide (PI) after incubation at 65°C for 5 min. Dead cells are stained with PI. Results are means (n = 3) of % PI-positive cells ± SD (error bars). Double asterisk (**) indicates p value < 0.005 using a Student’s t-test. (E) With a starting OD600 of 0.1, cells were grown in liquid culture (-URA synthetic medium) at 39°C and OD600 was measured at different time points. Data was collected from four biological replicate experiments (n=4) and the mean OD600 ± SD (error bars) was calculated for each time point. Double asterisk (**) indicates p value < 0.005 using a Student’s t-test. For all statistical analysis associated with Figure 1, p values are reported in the Figure 1—source data 1.

Figure 1—source data 1

Quantification and statistical analysis for viability stain measurements (Figure 1D) and cell growth measurements (Figure 1E and Figure 1—figure supplement 1).

https://cdn.elifesciences.org/articles/58155/elife-58155-fig1-data1-v2.xlsx

Next, we analyzed the role of Ser57 phosphorylation in the oxidative stress response. Wildtype yeast cells arrest growth in response to oxidative stress and activate responses that help cells cope with the proteotoxic and DNA damaging effects of oxidation (Silva et al., 2015; Shapira et al., 2004; Petti et al., 2011; Martindale and Holbrook, 2002). Interestingly, while yeast cells expressing wildtype or S57D ubiquitin arrested growth in response to moderate oxidative stress (>1 mM H2O2), cells expressing S57A ubiquitin were deficient in this response and only arrested growth in response to more severe oxidative stress (>2 mM H2O2) (Figure 2A). The failed growth arrest observed for cells expressing S57A ubiquitin correlated with decreased viability (Figure 2B). Since oxidative stress induces the production of both K48- and K63-linked ubiquitin conjugates (Shang and Taylor, 2011; Silva et al., 2015; Sun et al., 2009; Tsirigotis et al., 2001) we tested if the expression of S57A and S57D ubiquitin alters ubiquitin conjugation patterns in response to oxidative stress. We found that 30 min exposure to H2O2 (1.0 mM) resulted in an increased abundance of total ubiquitin conjugates (Figure 2C) as well as K48-linked polymers (Figure 2C–D), consistent with a previous report (Silva et al., 2015). Compared to cells expressing wildtype ubiquitin, we found that cells expressing S57D ubiquitin exhibited increased abundance of K48-linked polymers and decreased abundance of K63-linked polymers (Figure 2C–E). By contrast, cells expressing S57A ubiquitin did not exhibit a significant increase in the production of K48-linked polyubiquitin chains in response to oxidative stress (Figure 2C–D). Since substitutions at the Ser57 position of ubiquitin (S57A, S57D) might interfere with the recognition of ubiquitin polymers by linkage-specific antibodies, we used SILAC-MS to analyze how the expression of phosphomimetic (S57D) ubiquitin affects ubiquitin polymer linkage abundance compared to wildtype ubiquitin during conditions of oxidative stress. Consistent with the immunoblot results, this analysis revealed that S57D expression increases the production of K48-linked polymers by 39% during oxidative stress (Figure 2—figure supplement 1 and Supplementary file 1). (Notably, K63-linked polymers are a blind spot of this analysis, since the K63-linked ubiquitin remnant peptide also harbors the Ser57 position which is mutated to Asp in the light channel of this experiment.) It is worth noting that complete ubiquitin replacement in these cells exaggerates the impact physiological phosphorylation of ubiquitin is likely to have on global poly-ubiquitin linkage abundance. Indeed, we found that oxidative stress induced an approximately two-fold increase in phosphorylation of ubiquitin at the Ser57 position (Figure 2F and Figure 2—figure supplement 2). Based on previous measurements (Swaney et al., 2015; Lee et al., 2017), this stress-induced ubiquitin phosphorylation remains sub-stoichiometric and may have localized effects but is unlikely to alter global poly-ubiquitin linkage patterns. Ultimately, a deeper understanding of how Ser57 phosphorylated ubiquitin contributes to cellular stress responses will require the identification and characterization of the kinases that produce it.

Figure 2 with 2 supplements see all
Ser57 phosphorylation of ubiquitin is important for the yeast oxidative stress response.

(A) OD600 of yeast cells cultured in YPD with different concentrations of H2O2 for 48 hr (starting OD600 = 0.025). Data was collected for four biological replicate experiments (n=4) and the means ± SD (error bars) were calculated. Double asterisk (**) indicates p value < 0.005 between the range of 0.5 mM to 2.5 mM H2O2 using a Student’s t-test, which was only observed for yeast expressing S57A ubiquitin. (B) CFU count of cells treated with 1.5 mM H2O2 for 20 min. Untreated control was taken before H2O2 treatment. Data was collected for three bioloigcal replicate experiments (n = 3) and the means ± SD (error bars) were calculated. Double asterisk (**) indicates p value < 0.05 comparing untreated to H2O2 treated cells using a Student’s t-test, which revealed that only yeast expressing S57A ubiquitin experienced a significant loss of viability during H2O2 treatment in this experiment. (C) Western blot with anti-ubiquitin, anti-K48 ubiquitin, and anti-K63 ubiquitin antibodies of lysates from cells treated with 1 mM H2O2 for 30 min. (D and E) Quantification of results from the experiment shown in (C) is presented as the mean of four biological replicate experiments (n = 4) ± SD (error bars). Double asterisk (**) indicates p value < 0.005 comparing untreated to H2O2 treated cells using a Student’s t-test. Correspondingly, p values > 0.05 are labeled as not significant (n.s.). Cells used in A-E are SUB280-derived strains exclusively expressing WT, S57A, or S57D ubiquitin variants. (F) SILAC-MS of affinity purified 3XFLAG-ubiquitin from yeast cells (JMY1312) treated with 0.6 mM H2O2 for 30 minutes. The peptide corresponding to Ser57 phosphorylation is colored red, while peptides corresponding to K48- and K11-linked poly-ubiquitin are colored blue and green, respectively. All other ubiquitin-derived peptide measurements are represented with black dots. All individual measurements and p values derived from statistical tests associated with the data in this figure are reported in Figure 2—source data 1.

Figure 2—source data 1

Quantification and statistical analysis for the growth (Figure 2A), cell viability (Figure 2B), and anti-K48/K63 western blot analysis (Figure 2D–E) of cells in the presence or absence of H2O2.

The source data for both replicates in Figure 2F are also included.

https://cdn.elifesciences.org/articles/58155/elife-58155-fig2-data1-v2.xlsx

To identify candidate ubiquitin kinases, we screened for Ser57 phosphorylation activity by co-expressing ubiquitin and yeast kinases in E. coli and immunoblotting lysates using an antibody specific for Ser57 phosphorylated ubiquitin. Initially, we focused on candidate kinases for which mutants exhibit phenotypes corresponding to those observed for cells expressing S57A or S57D ubiquitin. We found that co-expression of ubiquitin with the kinase Vhs1 resulted in immunodetection of Ser57 phosphorylated ubiquitin (Figure 3A and Figure 3—figure supplement 1). Vhs1 is part of the yeast family of Snf1-related kinases (Tumolo et al., 2020), and additional screening revealed three other kinases in this family that phosphorylated ubiquitin at the Ser57 position: Sks1 (which is 43% identical to Vhs1) (Figure 3B), Gin4 and Kcc4 (Figure 3—figure supplement 2). A previous study reported consensus phosphorylation motifs for Vhs1, Gin4, and Kcc4, and all bear similarity to the amino acid sequence surrounding Ser57 in ubiquitin (Supplementary file 2; Mok et al., 2010).

Figure 3 with 13 supplements see all
A subset of the Snf1-related family of kinases phosphorylates ubiquitin at the Ser57 position.

(A) Anti-phospho-Ser57 western blot of E. coli Rosetta 2 (DE3) lysates co-expressing ubiquitin and yeast kinases. (B) Anti-phospho-Ser57 western blot of E. coli Rosetta 2 (DE3) lysates co-expressing ubiquitin (wildtype, S57A, or S65A variants) and Sks1, a paralog of Vhs1. (C and D) In vitro reconstitution of ubiquitin Ser57 phosphorylation using purified recombinant Vhs1 (C) and Sks1 (D). Ubiquitin monomers as well as linear (M1-linked) dimers and trimers were included in equal amounts. Numerical values above each lane represent reaction time for the sample. (E and F) SILAC-MS of IP-enriched 3XFLAG ubiquitin from yeast cells (JMY1312 background) with either empty vector or with vector for overexpression of Sks1 (E) or Vhs1 (F). Black and red dots indicate resolved ubiquitin peptides and Ser57-phosphopeptides, respectively. All individual measurements are reported in Figure 3—source data 1. (G) In vitro activity assay of select human kinases of the AMPK family using equal amounts of mono-ubiquitin and M1-linked tetra-ubiquitin as substrates.

Figure 3—source data 1

Source measurements for the H:L ratio of ubiquitin peptides resolved in all replicate experiments of SUB280 cells overexpressing Sks1 (Figure 3E) or Vhs1 (Figure 3F).

https://cdn.elifesciences.org/articles/58155/elife-58155-fig3-data1-v2.xlsx

We further characterized the activity of Vhs1 and Sks1. Analysis of Vhs1 and Sks1 activity using Phos-tag acrylamide gels (Figure 3—figure supplement 3) confirmed the production of Ser57 phosphorylated ubiquitin. Using purified recombinant Vhs1 and Sks1, we reconstituted kinase activity toward Ser57 of ubiquitin and found that both kinases exhibited a preference for polymers (tri-ubiquitin > di ubiquitin > mono ubiquitin) although the activity of Sks1 was noticeably greater than that of Vhs1 (Figure 3C–D and Figure 3—figure supplement 4–5). Analysis of linkage specificity in the phosphorylation reaction revealed that Vhs1 is active toward linear (M1-linked), K29-, and K48-linked tetramers, while Sks1 is active toward linear, K48-, and K63-linked polymers (Figure 3—figure supplement 6). These differences in linkage-specific activities in vitro may underlie non-overlapping functions for these two kinases in vivo. To test if the observed in vitro activity correlated with in vivo activity, we used SILAC to quantify changes to ubiquitin modifications following over-expression of Vhs1 or Sks1. Importantly, we observed that overexpression of either Vhs1 or Sks1 increased ubiquitin phosphorylation at the Ser57 position (Figure 3E–F and Figure 3—figure supplement 7–8). Interestingly, this analysis also revealed a number of phosphopeptides derived from Vhs1 within its kinase domain (Ser86) and its Ser-rich C-terminus (Figure 3—figure supplement 9), suggesting that Vhs1 itself may be subject to complex phospho-regulation. Taken together our data indicate that Vhs1 and Sks1 are bona fide ubiquitin kinases that specifically phosphorylate the Ser57 position.

The family of Snf1-related kinases in yeast share homology with the human AMPK-related kinases (Tumolo et al., 2020). To test if human AMPK-related kinases exhibit activity toward ubiquitin, we performed in vitro kinase assays and found that a subset of this family phosphorylated ubiquitin at the Ser57 position specifically on tetramers (Figure 3G). This activity was apparent in the MARK kinases (MARK1-4) as well as related kinases SIK1 and SIK2. It is noteworthy that other candidate human ubiquitin kinases (initially identified by commercial screening services) did not exhibit Ser57 ubiquitin kinase activity in vitro (Figure 3—figure supplement 10). Mass spectrometry analysis confirmed production of Ser57 phosphorylated ubiquitin by MARK2 in vitro (Figure 3—figure supplement 11). Further analysis of MARK2 activity toward linkage-specific ubiquitin tetramers revealed a preference for linear, K11-, K29-, and K63-linked tetramers (Figure 3—figure supplement 12). Given that Ser57 ubiquitin phosphorylation activity was detected within yeast and human Snf1-related kinases (Figure 3—figure supplement 13), we propose that this is an evolutionarily conserved function for a subset of kinases within this family.

In an effort to understand the biological functions of Ser57-phosphorylated ubiquitin in yeast, we examined whether the deletion or overexpression of Ser57 ubiquitin kinases phenocopies expression of S57A or S57D ubiquitin, respectively (Figure 1A–B and Figure 2A). We did not observe heat tolerance phenotypes associated with deletion or overexpression of Ser57 ubiquitin kinases (Figure 4—figure supplement 1–2). However, yeast cells overexpressing VHS1 exhibited resistance to canavanine and thialysine (Figure 4A–B and Figure 4—figure supplement 3), reminiscent of canavanine and thialysine resistance conferred by S57D expression (Figure 1A; Lee et al., 2017). Overexpression of a catalytic dead variant (vhs1-K41R, which harbors a mutation in the conserved ATP binding pocket of the kinase domain) did not confer canavanine or thialysine resistance (Figure 4A–B and Figure 4—figure supplement 3). Importantly, the canavanine and thialysine resistance associated with VHS1 overexpression was suppressed in the presence of S57A ubiquitin (Figure 4C–D and Figure 4—figure supplement 4), indicating the phenotypes are driven by the production of Ser57-phosphorylated ubiquitin. We also observed that yeast cells overexpressing SKS1 exhibited hypersensitivity to hydroxyurea (Figure 4—figure supplement 5), consistent with the hydroxyurea sensitivity phenotype observed in yeast cells expressing S57D ubiquitin (Figure 1A). The hydroxyurea hypersensitivity associated with SKS1 overexpression was suppressed in the presence of S57A ubiquitin (Figure 4E), indicating the phenotype requires Ser57 phosphorylation of ubiquitin. Taken together, these phenotypic correlations suggest that Vhs1 and Sks1 exert stress phenotypes associated with the phosphorylation of ubiquitin at the Ser57 position.

Figure 4 with 5 supplements see all
Regulation of proteotoxic stress responses by Ser57 ubiquitin kinases.

(A) Analysis of yeast strains containing high copy plasmids (empty vector, VHS1, or a kinase dead (vhs1 K41R) variant) grown on the indicated synthetic media plates. (B) Analysis of the same yeast strains in (A) grown in liquid culture containing canavanine (4 µg/mL). Values in each time point are means of three biological replicates (n = 3) and ± SD (error bars). Double asterisk (**) indicates p value < 0.005 at the 14 and 24 hr time points using a Student’s t-test, which was only observed for yeast overexpressing wildtype VHS1. (C) Analysis of yeast strains (SUB280 background, expressing either WT or S57A ubiquitin) containing the indicated high copy plasmids (empty vector or harboring VHS1 or SKS1) grown on the indicated synthetic media plates. (D) Analysis of the same yeast strains in (C) grown in liquid culture containing canavanine (4 µg/mL). Values in each time point are means of three biological replicates (n = 3) and ± SD (error bars). Double asterisk (**) indicates p value < 0.005 at the 14 and 24 hr time points using a Student’s t-test, which was only observed for yeast overexpressing wildtype VHS1 and expressing wildtype ubiquitin. (E) Analysis of yeast strains (SUB280 background, expressing either WT or S57A ubiquitin) containing the indicated high copy plasmids (empty vector or harboring VHS1 or SKS1) grown on the indicated synthetic media plates. (F) Analysis of the growth response to oxidative stress in WT and Δsks1Δvhs1 double mutant cells, with indicated complementation expression vectors. OD600 of cells (n = 4; ± SD error bars) in dropout SM media in the absence or presence of 1.5 mM H2O2 after incubation at 24 hr or 48 hr, respectively. Starting OD600 of 0.025 and data was collected for four biological replicate experiments (n=4). Double asterisk (**) indicates p value < 0.001 compared to wildtype yeast treated with H2O2 using a Student’s t-test, which was observed for yeast expressing empty vector, VHS1 individually, or SKS1 individually but not for yeast expressing both VHS1 and SKS1. (G) Analysis of the growth response to oxidative stress in WT and Δsks1Δvhs1 double mutant cells, with indicated ubiquitin expression vectors. OD600 of cells (n = 4; ± SD error bars) in dropout SM media in the absence or presence of 1.5 mM H2O2 after incubation at 24 hr or 48 hr, respectively. Starting OD600 of 0.025 and data was collected for four biological replicate experiments (n=4). Double asterisk (**) indicates p value < 0.001 compared to wildtype yeast treated with H2O2 using a Student’s t-test, which was observed for yeast expressing empty vector, wildtype ubiquitin, or S57A ubiquitin but not S57D ubiquitin. (H) Chromatography data serving as the basis for quantification of Ser57 phosphorylation corresponding to Table 1. Yeast cells expressing endogenous FLAG-ubiquitin (JMY1312 [SEY6210 background] parent cells) were cultured in heavy (H; wildtype cells [blue trace]) or light (L, isogenic Δvhs1Δsks1 deletion [red trace]) SILAC media to the mid-log phase and cells were treated with 1 mM H2O2 for 30 min before harvesting. Following cell lysis and overnight tryptic digestion of affinity-purified FLAG-ubiquitin, phospho-peptides were enriched using IMAC chromatography (see Materials and Methods) and analyzed by mass spectrometry. The Ser57 phosphopeptide is represented in the right panel, while the corresponding unmodified peptide is depicted in the left panel. All individual measurements and p values derived from statistical tests associated with the data in this figure are reported in Figure 4—source data 1.

Figure 4—source data 1

Quantification and statistical analysis for growth tolerance in canavanine (Figure 4B and D), thialysine (Figure 4—figure supplements 3 and 4), and hydrogen peroxide (Figure 4E and F).

https://cdn.elifesciences.org/articles/58155/elife-58155-fig4-data1-v2.xlsx

We also examined whether the deletion of Ser57 ubiquitin kinases phenocopied the oxidative stress response defect observed for yeast cells expressing S57A ubiquitin (Figure 2A). Notably, Δsks1Δvhs1 double mutant cells failed to arrest growth in response to oxidative stress, a phenotype that could only be complemented by the re-introduction of both VHS1 and SKS1 (Figure 4F). This phenotype of Δsks1Δvhs1 double mutant cells was also suppressed by the expression of S57D (but not WT or S57A) ubiquitin (Figure 4G) suggesting that the growth arrest defect in Δsks1Δvhs1 cells is linked to a deficiency in the production of ubiquitin phosphorylated at the Ser57 position. To explore this further, we used SILAC-MS to compare levels of Ser57 phosphorylated ubiquitin in untreated or H2O2-treated cells, however, this analysis did not reveal significant changes in Δsks1Δvhs1 cells (Figure 4H and Table 1). While these results indicate that Sks1 and Vhs1 are dispensable for production of Ser57 phosphorylated ubiquitin in the acute phase of the oxidative stress response, we cannot exclude roles for these kinases during prolonged exposure to oxidative stress or the possibility that they contribute to the phosphorylation of localized pools of ubiquitin.

Table 1
Corresponds to Figure 4H.

Analysis of ubiquitin phosphorylation in Δvhs1Δsks1 mutants. Yeast cells expressing endogenous FLAG-ubiquitin (JMY1312 [SEY6210 background] parent cells) were cultured in heavy (H; wildtype cells) or light (L, isogenic Δvhs1Δsks1 deletion) SILAC media to the mid-log phase. In Experiment #1, cells were untreated, and in Experiment #2 cells were treated with 1 mM H2O2 for 30 min before harvesting cells. Following cell lysis and overnight digestion of lysates with trypsin, phospho-peptides were enriched using IMAC chromatography (see Materials and methods) and analyzed by mass spectrometry. Phosphorylated ubiquitin peptides resolved in these experiments are indicated and the values presented in the table represent the H:L SILAC ratio, which has been normalized to the total ubiquitin H:L ratio for each experiment and log-transformed (log2). ‘n.d.’ for Ser19 in Experiment #1 indicates that this peptide was identified but could not be quantified in this experiment due to poor quality of chromatographic data.

PeptidePhospho- sitelog2 (H:L Ratio)
Expt #1Expt #2
TITLEVE[pS]SDTIDNVKSer19n.d.0.18
TL[pS]DYNIQKSer570.06−0.06
ES[pT]LHLVLRThr66−0.220.11

Discussion

The data presented here provide evidence that Ser57 phosphorylated ubiquitin and the kinases that produce it play an important role in several yeast stress responses, but the low stoichiometry of this modification suggests its effects are likely limited and localized in a physiological context. To the best of our knowledge, this study reports the first Ser57 ubiquitin kinases, and the only known ubiquitin kinases besides PINK1. Importantly, PINK1 activity is tightly regulated and highly localized to the outer membrane of damaged mitochondria. One potential explanation of the genetic and biochemical data presented here is that Sks1 and Vhs1 phosphorylate a localized pool (or pools) of ubiquitin in response to stress. However, the data also indicate that Sks1 and Vhs1 are not required for the production of Ser57 phosphorylated ubiquitin during normal growth or oxidative stress (Figure 4H and Table 1). This may be due to redundancy of kinase activities, possibly with Gin4, Kcc4, or other as-yet-unidentified ubiquitin kinases. However, such redundancy cannot explain the phenotypes observed during oxidative stress, since Δsks1Δvhs1 double mutant cells exhibit oxidative stress phenotypes that are suppressed by expression of phosphomimetic (S57D) ubiquitin (Figure 4G). In this case, we propose that a localized pool of ubiquitin phosphorylated by Sks1 and Vhs1 is critical for the oxidative stress response but is not resolved in our proteomic analysis, or only contributes a small fraction to a larger pool. This interpretation reconciles the genetic and biochemical data presented here, and it is consistent with the precedent established with PINK1, which is subject to tight regulation and contributes to localized production of Ser65 phosphorylated ubiquitin. However, further characterization of the Ser57 ubiquitin kinases reported here and analysis of localized ubiquitin pools will be required to validate this interpretation.

Genetic experiments presented here reveal that ubiquitin replacement with phosphomimetic ubiquitin phenocopies kinase gain of function (as is the case with canavanine, thialysine, and hydroxyurea sensitivities) while replacement with phosphorylation resistant ubiquitin phenocopies kinase loss of function (as is the case with sensitivity to H2O2). An important limitation of this genetic analysis is the built-in assumption that ubiquitin variants (phosphomimetic or phosphorylation resistant) behave as expected and do not alter other biochemical properties of ubiquitin in a cellular context. Additionally, such phenotypes associated with ubiquitin variants are likely to over-estimate the physiological effects of ubiquitin phosphorylation. In the case of phospho-mimetic (S57D) ubiquitin, this is because physiological ubiquitin phosphorylation is sub-stoichiometric. In the case of phosphorylation resistant (S57A) ubiquitin, this may be due to redundancy of kinases. Such redundancy seems likely since we identified multiple Ser57 ubiquitin kinases (Vhs1, Sks1, Gin4, and Kcc4) and the deletion of two kinases did not decrease the production of Ser57 phosphorylated ubiquitin (Figure 4H and Table 1). Furthermore, we cannot exclude the possibility that mutation of Ser57 alters the biochemical properties of ubiquitin in such a way as to phenocopy the effects associated with kinase deletion and/or overexpression. Going forward, these limitations present formidable challenges for dissecting the biological functions of ubiquitin phosphorylation, which is why the identification and characterization of ubiquitin kinases is critical. Ultimately, deeper characterization of Ser57 ubiquitin kinases – particularly to understand their localization and regulation in the context of proteotoxic stress – will likely be critical to understanding how phosphorylation regulates the biology of the ubiquitin code.

Materials and methods

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
Strain, strain background
(S. cerevisiae)
SUB280D. Finley Lab; Finley et al., 1994
PMID:8035826
PMCID:PMC359070
MATa, lys2-801, leu2-3, 112, ura3-52, his3-D200, trp 1–1, ubi1-D1::TRP1, ubi2-D2::ura3, ubi3-Dub-2, ubi4-D2::LEU2 [pUB39 Ub, LYS2] [pUB100, HIS3]
Strain, strain background
(S. cerevisiae)
SUB280 Ub (WT, S57A, S57D)Lee et al., 2017
PMID:29130884
PMCID:PMC5706963
MATa, SUB280 [RPS31 (WT, S57A, S57D; URA3)]
Strain, strain background
(S. cerevisiae)
NHY318This paperMATa, SUB280 arg4::KANMX
Strain, strain background
(S. cerevisiae)
SEY6210S. Emr Lab; Robinson et al., 1988
PMID:3062374
PMCID:PMC365587
RRID:ATCC: 96099WT: MATα leu2-3,112 ura4-52 his3-D200 trp1-D901 lys2-801 suc2-D9
Strain, strain background
(S. cerevisiae)
SEY6210.1S. Emr Lab; Robinson et al., 1988
PMID:3062374
PMCID:PMC365587
WT: MATa leu2-3,112 ura4-52 his3-D200 trp1-D901 lys2-801 suc2-D9
Strain, strain background
(S. cerevisiae)
NHY175This paperMATα, SEY6210 gin4::NATMX
Strain, strain background
(S. cerevisiae)
NHY117This paperMATα, SEY6210 sks1::TRP1
Strain, strain background
(S. cerevisiae)
NHY118This paperMATα, SEY6210 vhs1::TRP1
Strain, strain background
(S. cerevisiae)
NHY196This paperMATa, SEY6210.1 sks1::TRP1 vhs1::TRP1
Strain, strain background
(S. cerevisiae)
NHY177This paperMATα, SEY6210 gin4::NATMX sks1::TRP1
Strain, strain background
(S. cerevisiae)
NHY179This paperMATα, SEY6210 gin4::NATMX vhs1::TRP1
Strain, strain background
(S. cerevisiae)
NHY181This paperMATα, SEY6210 gin4::NATMX sks1::TRP1 vhs1::TRP1
Strain, strain background
(S. cerevisiae)
JMY1312This paperMATα, SEY6210 arg4::KANMX FLAG-RPS3::TRP1, FLAG-RPL40B::TRP1
Strain, strain background
(S. cerevisiae)
NHY326This paperMATa, JMY1312 sks1::TRP1 vhs1::TRP1
Strain, strain background
(E. coli)
Rosetta 2 (DE3)Millipore (Burlington, MA)Cat# 71400F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR)
Competent Cells - Novagen
Strain, strain background
(E. coli)
C41 (DE3)Lucigen Corporation (Middleton, WI)F ompT hsdSB (rB - mB -) gal dcm (DE3)
Competent Cells
Recombinant DNApRS415Stratagene(Empty Backbone) Yeast Centromere Plasmid (LEU2)
GenBank: U03449
Recombinant DNApRS416Sikorski and Hieter, 1989(Empty Backbone) Yeast Centromere Plasmid (URA3)
GenBank: U03450
Recombinant DNApJAM1303This paperpNative-Sks1 in pRS416 (URA3); yeast expression
Recombinant DNApJAM1304This paperpNative-Sks1 in pRS415 (LEU2); yeast expression
Recombinant DNApJAM1280This paperpTDH3-Sks1 in pRS415 (LEU2); yeast expression
Recombinant DNApJAM1253This paperpNative_Vhs1 in pRS415 (LEU2); yeast expression
Recombinant DNApRS327PMID:14989082RRID:Addgene_51787(Empty Backbone) multicopy (YEp) vector with a 2 μm origin of replication (LYS2); yeast expression
Recombinant DNApJAM1746This paperpTDH3-Gin4 in pRS327; yeast expression
Recombinant DNApJAM1749This paperpTDH3-Kcc4 in pRS327; yeast expression
Recombinant DNApJAM1743This paperpTDH3-Sks1 in pRS327; yeast expression
Recombinant DNApJAM1740This paperpTDH3-Vhs1 in pRS327; yeast expression
Recombinant DNApJAM1771This paperpTDH3-Vhs1 K41R (kinase dead) in pRS327; yeast expression
Recombinant DNApJAM1240This paper6XHis-Sks1 in pET15b, AmpR; E. coli expression
Recombinant DNApJAM1169This paperVhs1-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM983This paperGin4-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1116This paperHal4-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1118This paperHal5-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1120This paperKkq8-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1336This paperSnf1-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM585This paper6XHis-Npr1 in pCOLADuet, KmR; E. coli expression
Recombinant DNApJAM1270This paperKsp1-6XHis in pET23d,
AmpR; E. coli expression
Recombinant DNApJAM1186This paperGST-Slt2 in pGEX6p1; E. coli expression
Recombinant DNApJAM1335This paperFrk1-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM987This paperKcc4-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1306This paperKin1-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1307This paperKin2-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1272This paperYpl150w-6XHis in pET23d, AmpR; E. coli expression
Recombinant DNApJAM1167This paper6XHis-GST-UBD, AmpR;E. coli expression
Recombinant DNApJAM1235This paperUbiquitin in pBG100; E. coli expression
Recombinant DNApJAM1236This paperUbiquitin S57A in pBG100; E. coli expression
Recombinant DNApJAM1237This paperUbiquitin S65A in pBG100; E. coli expression
Recombinant DNApJAM995This paperdi-Ub in pET23d, AmpR; E. coli expression
Recombinant DNApJAM996This papertri-Ub in pET23d, AmpR; E. coli expression
Antibodyα-Flag (FLAG(R) M2) mouse monoclonalSigma (St. Louis, MO)RRID:AB_262044WB (1:1000)
Antibodyα-Ubiquitin (VU101) mouse monoclonal; clone VU-1LifeSensors (Malvern, PA)Cat# VU101
RRID:AB_2716558
WB (1:1000)
Antibodyα-Glucose-6-Phosphate Dehydrogenase (G6PDH), yeast rabbit polyclonalSigma (St. Louis, MO)Cat# A9521
RRID:AB_258454
WB (1:10000)
Antibodyα-pSer57 Ubiquitin rabbit polyclonalThis paperWB (1:1000)
AntibodyK48-linkage Specific Polyubiquitin rabbit monoclonal; clone D9D5Cell Signaling Technology (Danvers, MA)Cat# 8081
RRID:AB_10859893
WB (1:1000)
AntibodyK63-linkage Specific Polyubiquitin rabbit monoclonal; clone Apu3Millipore (Burlington, MA)Cat# 05–1308
RRID:AB_1587580
WB (1:1000)
AntibodyIRDye 680RD-Goat anti-mouse polyclonalLI-COR Biosciences (Lincoln, NE)Cat# 926–68070
RRID:AB_10956588
WB (1:10000)
AntibodyIRDye 800CW-Goat anti-rabbit polyclonalLI-COR Biosciences (Lincoln, NE)Cat# 926–32211
RRID:AB_621843
WB (1:10000)
Commercial assay, kitPTMScan Ubiquitin Remnant Motif (α-K-ε-GG)Cell Signaling Technology (Danvers, MA)RRID:Cat# 5562bead-conjugated for immunoprecipitation of –GG-εK-conjugated peptides
Chemical compound, drugEZ view Red Anti-FLAG M2 Affinity GelSigma (St. Louis, MO)Cat# F2426-1ML
RRID:AB_2616449
mouse-monoclonal; clone M2
bead-conjugated for immunoprecipitation of FLAG-conjugated proteins
Chemical compound, drugL-Lysine-13C6,13N2hydrochlorideSigma (St. Louis, MO)Cat# 608041–1G
Chemical compound, drugL-Arginine-13C6,13N4hydrochlorideSigma (St. Louis, MO)Cat# 608033–1G
Chemical compound, drugSodium arsenate dibasic heptahydrateSigma (St. Louis, MO)Cat# A6756Synonym: arsenate
Chemical compound, drugHydrogen peroxideFisher (Hampton, NH)Cat# H325-500Synonym: H2O2
Chemical compound, drugHydroxyureaINDOFINE Chemical Company, Inc (Hillsborough, NJ)Cat# BIO-216
Chemical compound, drugS-(2-Aminoethyl)-L-cysteine hydrochlorideSigma (St. Louis, MO)Cat# A2636-1GSynonym: L-4-Thialysine hydrochloride, thialysine
Chemical compound, drugL-CanavanineSigma (St. Louis, MO)Cat. # C1625Synonym: canavanine
Chemical compound, drugDL-2-Aminoadipic acidSigma (St. Louis, MO)Cat. # A0637
Chemical compound, drugMG132Apexbio (Houston, TX)Cat. # A2585
Chemical compound, drugProtease inhibitor cocktail (cOmplete Tablets, Mini)Roche (Basel, Switzerland)Cat# 04693159001
Chemical compound, drugPhosSTOPRoche (Basel, Switzerland)Cat# 04906837001
Chemical compound, drugPhos-tag AcrylamideNARDCat# AAL-107
Software, algorithmMaxQuant
Version 1.6.5.0
Max Planck Institute of BiochemistryRRID:SCR_014485
Software, algorithmSkyline
Version 20.1.0.155
MacCoss Lab SoftwareRRID:SCR_014080
Software, algorithmAdobe Illustrator CS5.1
Version 15.1.0
Adobe (San Jose, CA)RRID:SCR_010279
Software, algorithmImage Studio Lite
Version 5.2
LI-COR Biosciences (Lincoln, NE)RRID:SCR_013715

Cell strains and culture

Request a detailed protocol

All Saccharomyces cerevisiae strains and reagents used in this study are described in the Key Resources Table. SUB280 cells were used to shuffle different ubiquitin variants (wildtype, S57A, and S57D) by counterselection on URA-dropout SDM plates containing DL-2-aminoadipic acid as previously described (Lee et al., 2019; Sloper-Mould et al., 2001). Such SUB280-derived cells were used in growth sensitivity assays in different stress conditions. SEY6210 cells were used to generate gene-deletion strains by resistance marker-guided recombination and cross-mating methods. Yeast strains for mass spectrometry experiments were JMY1312 (with chromosomally tagged RPS31 and RPL40B) and its derivatives. Cells were cultured at 26°C in yeast-peptone-dextrose (YPD) or synthetic dextrose minimal medium (SDM: 0.67% yeast nitrogen base, 2% dextrose, and required amino acids) at 200 rpm agitation. SILAC media were supplemented with light lysine (12C614N2 L-Lys) and arginine (12C614N4 L-Arg), or heavy isotopes of lysine (13C615N2 L-Lys) and arginine (13C615N4 L-Arg). For spot plate dilution assay, cells were grown for 18–24 hr, normalized to OD600 of 1.0, and sequentially diluted at 1:10 dilution onto SDM agar plates containing amino acid dropout mixture in the absence or presence of 2.5 mM NaH2AsO4, 200 mM hydroxyurea, 2.0 µg/mL canavanine, and 6.0 µg/mL thialysine. For H2O2 sensitivity assay, yeast cells grown to the mid-log phase (OD600 of 0.7) were diluted to OD600 of 0.025 with 1.5 mM H2O2 in SDM and terminal OD600 of cells was measured after 1–3 days of incubation. For growth sensitivity assay of liquid cultures, cells were grown for 18 hr at 26°C, normalized to OD600 of 5.0, and subcultured into fresh media with a starting OD600 of 0.1. OD600 of cells was recorded at different time points until cells reach the stationary phase. For bacterial cultures, the yeast kinase and ubiquitin were heterologously co-expressed in E. coli Rosetta 2 (DE3) by 1 mM IPTG induction at 26°C for 16 hr.

Protein preparation

Protein precipitation

Request a detailed protocol

Yeast proteins were precipitated by adding ice-cold 10% trichloroacetate in TE buffer (2 mM EDTA, 10 mM Tris-HCl, pH 8.0), washed with 100% acetone, and lyophilized by vacuum centrifugation. Desiccated protein was resolubilized in urea sample buffer.

Recombinant protein expression and purification of kinases

Request a detailed protocol

N-terminally tagged Vhs1 or Sks1 were produced in E. coli C41(DE3) cells cultured in LB Media. Cells were induced at an OD600 of 0.6 with 1 mM IPTG and allowed to express for 4 hr at 37°C. Cells were pelleted by centrifugation at 6000 × g for 25 min and flash-frozen with liquid nitrogen. Before purification, the cells were thawed on ice, resuspended in 5 mL of lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 10 mM imidazole, 2 mM βME, complete protease inhibitors [Roche, Basel, Switzerland], 1 μg/mL DNase, 1 μg/mL lysozyme, and 1 mM PMSF) per 1 g of cells, and sonicated (21 min total, 5 s on and 10 s off). Cell lysates were cleared by centrifugation (50,000 × g for 30 min at 4°C) and filtered through a 0.45 μM filter. For purification, lysates were applied to Ni-NTA resin (Thermo Scientific, Rockford, IL) that had been equilibrated with lysis buffer containing 20 mM imidazole. The protein was eluted with lysis buffer containing 400 mM imidazole. Protein was buffer exchanged to remove imidazole (50 mM Tris pH 8.0, 100 mM NaCl, and 2 mM βME) and the purification tag was cleaved. The protein was loaded on a HiPrep Q FF Anion Exchange Column (GE Healthcare Life Sciences, Marlborough, MA) and eluted by buffer with 300 mM NaCl. Recombinant ubiquitin variants were purified using the Ni-NTA affinity protocol described above, followed by size exclusion chromatography using a HiLoad Superdex 75 pg column (GE Healthcare Life Sciences, Marlborough, MA). The protein was eluted in a buffer containing (50 mM Tris pH 7.5, 150 mM NaCl, and 2 mM DTT). Ubiquitin-containing fractions were pooled and concentrated by centrifugation to 1 mM.

Western blotting

Request a detailed protocol

Proteins in Laemmli buffer (for E. coli lysates) or urea sample buffer (for TCA-precipitated yeast proteins) containing 10% β-mercaptoethanol were resolved in 12–14% Bis-Tris PAGE gel by electrophoresis. Separated proteins were transferred onto PVDF membrane (0.2 µm, GE Healthcare Amersham) and immunoblotting was performed using the following primary antibodies: anti-ubiquitin (1:10,000; LifeSensors; MAb; clone VU-1), anti-K48 (1:10,000; Cell Signaling; RAb; clone D9D5), anti-K63 (1:4000; EMD Millipore; RAb; clone apu3), and anti-G6PDH (1:10,000; Sigma; RAb). Anti-mouse (IRDye 680RD-Goat anti-mouse) or anti-rabbit (IRDye 800CW-Goat anti-rabbit) secondary antibodies were purchased from LI-COR. Blots were visualized using Odyssey CLx (LI-COR Biosciences) and signal intensity was quantified using Image Studio Lite (LI-COR Biosciences).

Mass spectrometry

Request a detailed protocol

SILAC-based mass spectrometry for quantitation and mapping of ubiquitin phosphorylation sites was performed as previously described (Albuquerque et al., 2008; Lee et al., 2019). Briefly, an equal amount of JMY1312 cells (labeled with either light or heavy Arg and Lys) expressing endogenous 3XFLAG-RPS31 and 3XFLAG-RPL40B were harvested from the mid-log phase and disrupted by bead beating using ice-cold lysis buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM EDTA, 0.2% NP-40, 10 mM iodoacetamide, 1 mM 1,10-phenanthroline, 1× EDTA-free protease inhibitor cocktail [Roche], 1 mM phenylmethylsulfonyl fluoride, 20 µM MG132, 1× PhosStop [Roche], 10 mM NaF, 20 mM BGP, and 2 mM Na3VO4). Lysate was clarified by centrifugation at 21,000 × g for 10 min at 4°C and supernatant was transferred into a new tube and diluted with three-fold volume of ice-cold TBS (50 mM Tris-HCl, pH 7.5, 150 mM NaCl). 3XFLAG-ubiquitin in 12 mL diluted lysate was enriched by incubation with 50 µL of EZview anti-FLAG M2 resin slurry (Sigma) for 2 hr at 4°C with rotation. The resin was washed three times with cold TBS and incubated with 90 µL elution buffer (100 mM Tris-HCl, pH 8.0, 1% SDS) at 98°C for 5 min. The collected eluate was reduced with 10 mM DTT, alkylated with 20 mM iodoacetamide, and precipitated with 300 µL PPT solution (50% acetone, 49.9% ethanol, and 0.1% acetic acid). Light and heavy protein pellets were dissolved with Urea-Tris solution (8 M urea, 50 mM Tris-HCl, pH 8.0). Heavy and light samples were combined, diluted four-fold with water, and digested with 1 µg MS-grade trypsin (Gold, Promega) by overnight incubation at 37°C. Phosphopeptides were enriched by immobilized metal affinity chromatography (IMAC) using Fe(III)-nitrilotriacetic acid resin as previously described (MacGurn et al., 2011) and dissolved in 0.1% trifluoroacetic acid. Peptides with K-ε-GlyGly remnant were isolated by immunoprecipitation as described in the PTMScan Ubiquitin Remnant Motif Kit (Cell Signaling Technologies) protocol. The GlyGly-peptide and phosphopeptide solutions were loaded on a capillary reverse-phase analytical column (360 μm O.D. × 100 μm I.D.) using a Dionex Ultimate 3000 nanoLC and autosampler and analyzed using a Q Exactive Plus mass spectrometer (Thermo Scientific). Data collected were searched using MaxQuant (ver. 1.6.5.0) and chromatograms were visualized using Skyline (ver. 20.1.0.31, MacCoss Lab).

In vitro kinase activity

Request a detailed protocol

Kinase activity assays were performed in a reaction mixture containing 50 mM Tris (pH 7.4), 150 mM NaCl, 10 mM MgCl2, 0.1 mM ATP, 1 mM DTT, 0.5 µM ubiquitin, and 50 nM kinase. Reactions on linkage-specific ubiquitin polymers were carried out at 30°C for 30 min and quenched by adding an equal volume of Laemmli buffer with 10% β-mercaptoethanol and heating at 98°C for 10 min.

Data availability

All data generated or analyzed during this study are included in the manuscript and supporting files.

References

    1. Sikorski RS
    2. Hieter P
    (1989)
    A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae
    Genetics 122:19–27.

Article and author information

Author details

  1. Nathaniel L Hepowit

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Contribution
    Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing - original draft, Writing - review and editing
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7614-2756
  2. Kevin N Pereira

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Contribution
    Methodology
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5377-397X
  3. Jessica M Tumolo

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Contribution
    Investigation
    Competing interests
    No competing interests declared
  4. Walter J Chazin

    Department of Biochemistry, Vanderbilt University, Nashville, United States
    Contribution
    Conceptualization, Resources
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2180-0790
  5. Jason A MacGurn

    Department of Cell and Developmental Biology, Vanderbilt University, Nashville, United States
    Contribution
    Conceptualization, Supervision, Funding acquisition, Investigation, Writing - original draft, Project administration, Writing - review and editing
    For correspondence
    jason.a.macgurn@vanderbilt.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5063-259X

Funding

National Institutes of Health (R21 AG053562)

  • Jason A MacGurn

National Institutes of Health (R01 GM118491)

  • Jason A MacGurn

National Institutes of Health (R35 GM118089)

  • Walter J Chazin

National Institutes of Health (T32 CA119925)

  • Jessica M Tumolo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Acknowledgements

We are very grateful to K Rose for technical advice and assistance with quantitative mass spectrometry analysis. We are also grateful to B Brasher for technical advice and recommending reagents. We also thank T Graham for critical reading of the manuscript. JMT was funded by NIH training grant T32 CA119925. This research was supported by NIH grant R21 AG053562 (to JAM), R01 GM118491 (to JAM), and R35 GM118089 (to WJC).

Copyright

© 2020, Hepowit et al.

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Nathaniel L Hepowit
  2. Kevin N Pereira
  3. Jessica M Tumolo
  4. Walter J Chazin
  5. Jason A MacGurn
(2020)
Identification of ubiquitin Ser57 kinases regulating the oxidative stress response in yeast
eLife 9:e58155.
https://doi.org/10.7554/eLife.58155

Share this article

https://doi.org/10.7554/eLife.58155

Further reading

    1. Cell Biology
    Satoshi Ninagawa, Masaki Matsuo ... Kazutoshi Mori
    Research Advance

    How the fate (folding versus degradation) of glycoproteins is determined in the endoplasmic reticulum (ER) is an intriguing question. Monoglucosylated glycoproteins are recognized by lectin chaperones to facilitate their folding, whereas glycoproteins exposing well-trimmed mannoses are subjected to glycoprotein ER-associated degradation (gpERAD); we have elucidated how mannoses are sequentially trimmed by EDEM family members (George et al., 2020; 2021 eLife). Although reglucosylation by UGGT was previously reported to have no effect on substrate degradation, here we directly tested this notion using cells with genetically disrupted UGGT1/2. Strikingly, the results showed that UGGT1 delayed the degradation of misfolded substrates and unstable glycoproteins including ATF6α. An experiment with a point mutant of UGGT1 indicated that the glucosylation activity of UGGT1 was required for the inhibition of early glycoprotein degradation. These and overexpression-based competition experiments suggested that the fate of glycoproteins is determined by a tug-of-war between structure formation by UGGT1 and degradation by EDEMs. We further demonstrated the physiological importance of UGGT1, since ATF6α cannot function properly without UGGT1. Thus, our work strongly suggests that UGGT1 is a central factor in ER protein quality control via the regulation of both glycoprotein folding and degradation.

    1. Biochemistry and Chemical Biology
    2. Cell Biology
    Senem Ntourmas, Martin Sachs ... Dominic B Bernkopf
    Research Article

    Activation of the Wnt/β-catenin pathway crucially depends on the polymerization of dishevelled 2 (DVL2) into biomolecular condensates. However, given the low affinity of known DVL2 self-interaction sites and its low cellular concentration, it is unclear how polymers can form. Here, we detect oligomeric DVL2 complexes at endogenous protein levels in human cell lines, using a biochemical ultracentrifugation assay. We identify a low-complexity region (LCR4) in the C-terminus whose deletion and fusion decreased and increased the complexes, respectively. Notably, LCR4-induced complexes correlated with the formation of microscopically visible multimeric condensates. Adjacent to LCR4, we mapped a conserved domain (CD2) promoting condensates only. Molecularly, LCR4 and CD2 mediated DVL2 self-interaction via aggregating residues and phenylalanine stickers, respectively. Point mutations inactivating these interaction sites impaired Wnt pathway activation by DVL2. Our study discovers DVL2 complexes with functional importance for Wnt/β-catenin signaling. Moreover, we provide evidence that DVL2 condensates form in two steps by pre-oligomerization via high-affinity interaction sites, such as LCR4, and subsequent condensation via low-affinity interaction sites, such as CD2.